| LCINS | Lung cancer in never-smokers |
| WHO | World Health Organization |
| IHC | Immunohistochemistry |
| NSCLC | Non-Small-cell lung Cancer |
| LUAD | Lung Adenocarcinoma |
| SCC | Squamous Cell Carcinoma |
| LCC | Large-cell carcinoma |
| SCLC | Small-cell lung cancer |
| OS | Overall survival |
| PFS | Progression-free survival |
| pCR | Pathologic complete response |
| CXR | Chest X-ray |
| FDG-PET/CT | 18F-fluorodeoxyglucose positron emission tomography/computed tomography |
| EBUS-TBNA | Endobronchial ultrasound-guided transbronchial needle aspiration |
| NGS | Next generation sequencing |
| PCR | Polymerase chain reaction |
| PAHs | Polycyclic aromatic hydrocarbons |
| HCAs | Heterocyclic amines |
| ICIs | Checkpoint inhibitors |
| TMB | Tumor mutational burden |
| ADC | Antibody–Drug Conjugate |